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Abstract
Migraine headache (MH) is a very common disorder affecting 10–12% of the 
world’s adult population. The first line therapy for migraine is usually a combination 
of conservative treatments but some patients seem to be refractory. For this group 
of patients, the minimally invasive surgical treatment of migraine might offer a 
solution. Migraine is usually caused by extracranial sensitive nerve compression due 
vascular, fascial or muscular structures nearby. The aim of migraine surgery is to 
relieve such compression at specific trigger points located in the occipital, temporal 
and frontal regions. From June 2011 until July 2019, we performed MH decom-
pression surgeries in over 269 patients with either frontal, occipital, or temporal 
migraine trigger sites. In the occipital and temporal areas, nerve decompression 
was achieved by occipital and superficial temporal artery ligation, respectively. 
In patients suffering from frontal headache we performed both endoscopic nerve 
decompression and transpalpebral decompression. Among patient suffering from 
occipital migraine, 95% of them showed improvement of their condition, with 
86% reporting complete relief. As concern temporal migraine, positive outcome 
was achieved in 83% of the patients (50% complete elimination and 33% partial 
improvement). In patient suffering from frontal migraine, positive results were 
observed in 94% of the patients (32% complete elimination, 62% partial improve-
ment). Migraine is a common and debilitating condition that can be treated suc-
cessfully with minimally invasive surgical procedure especially for those patients 
non-responding to medical therapies.
Keywords: migraine, tension-type headache, surgical therapy,  
minimally invasive surgery
1. Introduction
Migraine headache (MH) is known to affect over 324.1 million people worldwide 
[1, 2]. However, MH is still widely undiagnosed and undertreated. In US alone, MH 
treatment cost accounts for over $17 billion each year, without taking into consid-
eration the indirect costs due to the 112 million annual workdays loss, which has an 
estimated cost of $14 billion [2–4]. Furthermore, MH has an even greater burden on 
patients’ everyday life, their families, and the society.
Despite its prevalence and debilitating nature, MH is still widely undiagnosed 
and undertreated. A combination of pharmacologic (both abortive and preventive 
drugs) and non-pharmacological interventions (such as behavioral and lifestyle 
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changes) are still the main treatment for MH patients. Nevertheless, most MH suf-
fers remain refractory and does not achieve satisfactory relief.
Among the numerous hypotheses proposed over the years regarding MH 
etiology, none has come to clearly highlight its true nature. Some researchers have 
proposed that MH might be originated from a central neurovascular phenomenon, 
others have hypnotized a cortical neuronal hyperexcitability, others a cortical 
spreading depression, others an abnormal modulation of brain nociceptive system, 
and eventually others have demonstrated a central/peripheral activation with sensi-
tization of the trigeminal system [2, 5]. But still MH pathophysiology is unclear and 
a matter of international debate.
Plastic surgeons were never looking for a surgical treatment for MH; however, 
this idea came into their eyes in 1999 following the reports made by patients that 
underwent corrugator supercilii muscle resection for forehead rejuvenation surgery 
and experienced elimination or improvement in their MH after [2, 5]. In 2000, 
Guyuron et al. [5] first reported in a retrospective study this association between 
corrugator supercilii muscle resection and disappearance or significant improve-
ment in MH attacks, paving the way for a new MH origin and thus a new treatment 
option. Indeed MH appeared to be triggered by a peripheral activation of the 
trigeminal nerve, due to overstimulation of its branches (trigger points), followed 
by peripheral and central sensitization [5] And therefor, surgical decompression of 
these trigger sites might end up as an effective treatment modality of MH.
In the following years, independent researchers demonstrated the efficacy of 
botulin toxin injection for the treatment of MH [2]. These evidences supported 
the hypothesis that MH was determined by the peripheral activation of trigeminal 
nerve branches.
The trigger site was defined as the point where the MH attack starts and cor-
responds to the anatomical area of potential irritation of the trigeminal nerve 
branches [2, 6]. As a pathophysiological consequence of the chronic mechanical 
stimulation and irritation of the trigeminal nerve terminal branches, calcitonin 
gene-related peptide, substance P, and neurokinin are released [2, 5, 6]. These 
neuropeptides may cause the activation of the trigeminovascular system and the 
neurogenic inflammation leading to meningeal irritation, altered microvascular 
blood flow, central and peripheral trigeminal sensitization recognized as hyperalge-
sia, and cutaneous allodynia.
Eventually, multiple anatomical studies strengthened the trigger point theory 
of MH origin by demonstrating that musculature, vessels, bony foramen, and 
fascial bands could entrap or compress nerve branches at proposed migraine trig-
ger sites [2, 6, 7].
Over the last 15 years, Guyuron conducted several studies providing foundation 
for this hypothesis and reported a reduction of the frequency, duration, and inten-
sity of MH by at least half in 80–90% of patients [2, 5, 7–9]. In the same years, other 
independent groups reported similar findings by employing Guyuron’s surgical 
approach, demonstrating the effectiveness of the procedure and the reproducibility 
of the results [2, 6]. However, the most striking evidence for the effectiveness of 
peripheral nerve decompression surgery for MH treatment came from a double-
blind, sham-controlled study of Guyuron et al. [2, 8]. In this trial, 49 patients 
underwent decompressive surgery, while 26 underwent sham surgery. At least 50% 
reduction in MH was reported from 57.7% of patients of the sham surgery group 
and 83.7% in the actual surgery group (p < 0.05). Moreover, 57.1% of actual surgical 
group reported complete elimination of MH symptoms, compared with only 3.8% 
of patients in the sham surgery group (p < 0.001). At 1 year, all migraine headache 
measurements were significantly improved in the actual surgical group and were 
not influenced by the trigger site.
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Following these studies, four were the main trigger sites identified:
1. I Trigger Site (Frontal): patients present with frontal symptoms; the glabellar 
muscles and/or supratrochlear and supraorbital vessels may irritate corre-
sponding nerves.
2. II Trigger Site (Temporal): patients with temporal headaches; the temporalis 
muscle or the superficial temporal artery may cause inflammation of the zygo-
matic temporal branch of the trigeminal nerve (ZTN) or the auriculotemporal 
nerve (ATN).
3. III Trigger Site (Rhinogenic): patients complain of paranasal and retrobulbar 
headaches; deviated septum, contact between the turbinates and the septum, 
concha bullosa, septa bullosa, and other intranasal abnormalities may irritate 
the trigeminal end branches. This site will not be covered in the present chap-
ter.
4. IV Trigger Site (Occipital): patients refer occipital symptoms: occipitalis, tra-
pezius, and semispinalis capitis muscles, fascial bands, or the occipital artery 
can irritate the greater occipital nerve (GON) and/or the lesser occipital nerve 
(LON).
Following these evidences, it came to be clearly known that an essential step 
was detecting the precise site of pain onset (the trigger point) [2, 10–12]. Although 
patients might report diffuse headache, once they were asked to locate where the 
pain begins, they could precisely pinpoint it with one fingertip, and that was where 
the surgical treatment had to be performed in order to release the putative nerve 
branch. Surgeons’ finger compression over the trigger point usually can evoke pain, 
thus confirming the exact location of trigger point. Nerve blocks and portable 
Doppler were also successfully investigated in order to confirm the trigger points 
and help less experienced surgeons, while preoperative botulinum toxin injections 
proved to be less useful. Lack or incomplete response should be carefully interpreted 
since it does not automatically exclude the suspected trigger point; indeed, incom-
plete release might have been performed. Careful analysis of patients’ symptoms 
and meticulous physical examination can reliably guide the surgical planning. 
Indeed, MH origin and surgical deactivation procedures resembles closely upper 
limb compressing neuropathies. Therefore, surgical treatment for MH can suc-
cessfully eliminate or reduce the MH frequency, intensity, and duration in a lasting 
manner, reducing the economic burden of MH sufferers, improving patients’ per-
formances and participation in daily life activities [2, 3–10]. But still, a percentage of 
patients are refractory to surgery [2, 7]. Possible explanations are that incomplete or 
incorrect detection of all of the trigger sites have occurred or that irritation sites are 
not correctly dealt by current surgical approaches [2, 6]. Rigorous patient screen-
ing and selection with proper identification of MH trigger points are mandatory 
for a successful surgical outcome; yet a thorough understanding of the anatomy is 
essential to ensure complete nerve release and prevent postoperative complications.
2. Surgical treatment
In order to be regarded eligible to undergo the surgery patients had to be diag-
nosed by a board-certified neurologist with: migraine without aura, tension-type 
headaches, or new daily persistent headaches with 4 or more attack each month for 
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at least 6 months. Also, patients that do not benefit from any medications for their 
headache might undergo the procedure. However, patients with cluster headache, 
episodic tension-type headache, or secondary headaches are considered ineligible to 
undergo our procedure. Furthermore a CT scan or an MRI study must be performed 
prior to be regarded eligible for migraine deactivation surgery in order to rule out 
any cause of secondary migraine headache.
2.1 Frontal trigger site
The supraorbital nerve is a sensory nerve originating from the frontal branch 
of the ophthalmic division of the trigeminal nerve. In the majority of the cases, 
it passes through a supraorbital notch, which can be occasionally completed by a 
fibrous band. Here the nerve displays an intimate relationship with the corrugator 
supercilii muscle. The reason why some patients do not respond to the surgical 
decompression of the only supraorbital nerve and need a more medial muscular 
resection is that the supratrochlear nerve may be involved [2, 13–16]. The supra-
trochlear nerve is the smallest terminal branch of the frontal nerve, which itself 
originates from the ophthalmic division of the trigeminal nerve. It emerges between 
the trochlea and the supraorbital foramen. Another source of compression can be 
the interaction of nerves with the vascular structures. The main vessels that may be 
involved are the supratrochlear and the supraorbital arteries.
Patients who suffered from frontal migraine headache can be treated with either 
endoscopic or transpalpebral approach. In our experience, we performed both pro-
cedures to decompress supraorbital and supratrochlear nerves [13–16]. However, 
endoscopic nerve decompression cannot be performed on patients with long 
foreheads (8 cm measured from the anterior hairline to the supraorbital ridge) or on 
patients with significant curvature to the forehead, as endoscopic access would have 
been difficult to impossible. In our experience, endoscopic approach did not allow 
to treat the vascular compression of supraorbital and supratrochlear nerves by cor-
responding ectasic arteries [2, 13–16]. Transpalpebral approach for frontal trigger 
site deactivation was performed by means a supratarsal crease incision involving 
up to two-thirds of the medial limit of the caudal portion of the conventional upper 
blepharoplasty incision. The upper eyelid, glabellar area, and the lower forehead 
were infiltrated with local anesthesia composed by 40-cc Carbocaine 1% + 40-cc 
NaCl 0.9% and 20-cc sodium bicarbonate 8.4%. After raising a skin-orbicularis 
oculi muscle flap above the level of the septum, the orbicularis muscle was dissected 
in a cephalic direction. The dissection was continued to the supraoribtal rim. The 
corrugator supercilii muscle protecting the supraorbital and supratrochlear nerves 
was elevated and by dissection the exposure of depressor supercilii muscle was 
performed. After selective myotomy of depressor and corrugator supercilii muscles, 
the lateral fibers of the procerus muscle encasing the supratrochlear nerve were 
dissected. Once the supraorbital and supratrochlear nerves were isolated, they were 
decompressed by the cauterization of the concomitant ectasic arteries. The cutane-
ous access was closed with absorbable sutures, and steri-strips were positioned at 
level of superior eyelids bilaterally. The endoscopic selective myotomies technique 
was performed with a single access by mean a specifically modified endoscope (Karl 
Storz, Tuttlingen, Germany). With the patient supine and the head in a neutral 
position, frontal trigger nerves were located. Skin markings were drawn above 
the eyebrow bilaterally, at the mid-pupillary line (supraorbital nerve) and 1 cm 
medially (supratrochlear nerve). Local anesthesia with diluted 40-cc Carbocaine 
1% + 40-cc NaCl 0.9% and 20-cc sodium bicarbonate 8.4% was injected in the fore-
head, between the glabellar region and about 2 cm behind the anterior hairline. A 
single 1.5-cm incision was then performed on the midline, 1 cm behind the frontal 
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hairline. All tissues were dissected until the periosteum layer. The lateral anatomic 
limit of the undermined area was the temporal region, bilaterally. In order to lift 
the frontal skin during the endoscopic procedure (and better visualize the anatomic 
structures) nylon 1-0 sutures were placed in the superciliary region at each side of 
both supratrochlear and supraorbital nerves bilaterally. Our modified endoscope 
(Karl Storz, Tuttlingen, Germany) consists of a 9-mm trocar with an air/insuffla-
tor/suction triple valve, a straight Hopkins telescope with fiber-light transmission, 
a Wittmöser operating sheath with a connection for high-frequency diathermy, and 
a specifically designed elliptical-tipped wire loop electrode for electrocautery. The 
modified endoscope was inserted through the incision in the subgaleal plane and 
used to perform endoscopically assisted section of the corrugator supercilii, depres-
sor supercilii, and procerus muscles bilaterally, with the purpose of decompressing 
the supraorbital and supratrochlear nerves bilaterally. At the end of the procedure, 
after an accurate hemostasis, the cutaneous access was closed with absorbable 
suture, without any drainage; a compressive bandage was positioned all around 
undermined region [2, 13–16] (Figure 1).
2.2 Temporal trigger site
The ATN and ZTN are the two primary trigger points in the temporal migraine. 
The ATN is one of the terminal braches of the mandibular (V1) division of the 
trigeminal nerve. The ZTN is one of the terminal braches of the maxillary division 
(V2) of the trigeminal nerve [17–21].
It is our experience that the ATN is more often involved than the ZTN as tem-
poral MH trigger given the close relationship with the superficial temporal artery 
(STA). Therefore, our surgical procedure primarily aims at eliminating the pulsatile 
irritation of the STA to the ATN by ligating the artery prior to and above the inter-
section or coiling segment. However, we perform ZTN decompression whenever 
STA-ATN relationship is not intraoperatively observed.
We perform both our personal decompression techniques under local assisted 
anesthesia [17].
For ATN decompression surgery, we usually marked a 1.5-cm incision where 
patients pinpoint the painful spot above the insertion of auricular helix at level of 
temporal area. A handheld Doppler was regularly used to locate the STA, since we 
Figure 1. 




observed 100% correlation rate between the trigger point identified and a close 
ATN-STA relationship (being either a simple crossover or a helical intertwining). 
Once the incision was made, dissection was taken with the help of blunt tipped 
scissors to expose and isolate both ATN and STA, which was ligated both proximally 
and caudally to the area of nerve-artery intersection [17].
When it was necessary to decompress the ZTN, we made 3-cm cutaneous incision 
8–10 mm behind the temporal hairline and took dissection deep to the deep temporal 
fascia by the blunt tip scissors. We opened the inferior temporal septum exposing the 
inferior temporal compartment that contains the ZTN, sentinel vessels, and tempo-
ral branches of facial nerve (that must be carefully preserved by incorporating it in 
the roof of the elevated flap). Then we widened the exit of the ZTN through tempo-
ral muscle and fascia, and the sentinel vessels were cauterized only when patients 
described a pulsating pain in the temporal region [17] (Figure 2).
2.3 Occipital trigger site
The common occipital headache symptoms here can be caused by the compres-
sion of the greater, lesser, and third occipital nerves. This is due to the presence of 
muscular and fascial entrapments and also because of their interaction with the 
vascular structures [2, 4, 7, 22]. The greater occipital nerve originates from the 
medial branch of the C2 dorsal root. It curves to reach the occipital region, running 
caudal to the inferior oblique muscle and sometimes piercing it. Then it reaches the 
semispinalis muscle, where it is possible to identify the deepest potential compres-
sion point of the nerve. The course of the nerve in the area of the superior nuchal 
Figure 2. 
Close auriculotemporal nerve (ATN) and superficial temporal artery (STA) relationship.
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line is variously described, because of the large anatomical variability that these 
structures present. The latest studies have shown the exact location of the intramus-
cular course of the nerve: it is located 3 cm below and 1.5 cm lateral to the occipital 
protuberance [2, 4, 7, 22]. Possible trigger points can be found at its entrance into 
the deep fascia underlying the semispinalis or the muscle itself or at level of the 
entrance of the nerve in the semispinalis capitis and trapezius muscles. Other pos-
sible compression is where the nerve pierces the tendinous insertion of the trapezius 
into the nuchal line [2, 4, 7, 22].
Because of the surgical decompression of the nerve, the semispinalis capitis and 
the trapezius together with the splenius and the occipital muscles are resected with 
multiple myotomies.
However, based on our study, the close relationship found between the great 
occipital nerve and the occipital artery in the region of the superior nuchal line is 
the principal trigger point of occipital migraine.
This artery is the main vessel running through the occipital area. It arises from 
the external carotid artery, and it runs medially to the mastoid process on the 
temporal bone. It then reaches the occipital region, boring the deep cervical fascia 
between the sternocleidomastoid and the cranial attachment of the trapezius. 
At this point it can be found in the subcutaneous layer leaving many convoluted 
branches and anastomosing with the contralateral artery [3]. In more than 50% of 
the cases, an intimate anatomical relationship was found. There are two possible 
types of interaction: they can coil together (70%) or the other possibility is a simple 
crossing (30%) with the nerve passing superficial to the artery [2, 4, 7, 22].
Furthermore, minor trigger sites are also described in this area [2, 4, 7, 22]. It is 
related to the lesser occipital nerves, which can be similarly compressed by fascial 
bands and the occipital artery branches. If the lesser occipital nerve is affected, it 
can be responsible of laterally located pain symptoms. It arises from C2 or rarely 
from C3 dorsal root; it emerges from the posterior border of the sternocleidomas-
toids, seldom piercing it, and then ascends along it. The emergence point was found 
with a 3-cm diameter located 6.5 cm from midline and 5.3 cm below the line drawn 
between the two external auditory canals.
Surgical treatment of occipital trigger site aims at removing the potential 
compression points of the greater and the lesser occipital nerve along their course 
throughout the semispinalis, the splenius and the trapezius muscles to the sub-
cutaneous tissue of the occipital scalp. The avulsion of the third occipital nerve 
(TON) during the occipital migraine surgery does not improve clinical outcomes. 
According to Guyuron et al. [7], Lin et al. [23], Dash et al. [24], and Lee et al. 
[25], the currently adopted procedure for treatment of the occipital trigger site, 
undertaken under general anesthesia, relies first on an incision in the occipital 
scalp and extensive undermining through which a small portion of the semi-
spinalis capitis muscle is removed. This muscle is usually pierced by the greater 
occipital nerve (GON), lesser occipital nerves (LON) bilaterally. Subsequently, a 
subcutaneous flap is transposed between the GON and the muscle to avoid nerve 
impingement [7, 23–25].
As regards our experience [26–28], we performed the occipital decompression 
surgical technique with the patient prone, under local assisted anesthesia. After 
injecting 40-cc of diluted Carbocaine 1% + 40-cc NaCl 0.9% and 20-cc sodium 
bicarbonate 8.4%, two horizontal occipital scalp incisions 5 cm in length were 
performed along the superior nuchal line bilaterally, at the location of arterial 
signal detected preoperatively by portable Doppler. Underneath the subcutaneous 
tissue, an accurate dissection of occipital, trapezius, splenius capitis and semispi-
nalis capitis muscles allowed to identify the GON and vascular bundle (occipital 
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artery). When we found a dilated (or frankly aneurysmatic) occipital artery in close 
connection with the GON, we ligated or cauterized the vessel without any other 
surgical maneuvers except for accurate hemostasis and skin closure.
In the remaining cases in which vascular compression was not found we adopted 
a more conventional approach based on neurolysis of the GON and LON by under-
mining the occipital, trapezius, splenius capitis and semispinalis capitis muscles 
and following the nerve course caudally as possible [26, 27]. At the end of the proce-
dure, after an accurate hemostasis, the cutaneous access was sutured with absorb-
able threads, without any drainage. No trichotomy was needed, and the scar from 
the incision was hidden in the patient’s hair. The total operative time was no longer 
than 90 min for bilateral incisions, but often it was less than 60 minutes when the 
relevant anatomical structures were easily identified [27, 28] (Figure 3).
3. Results
From June 2011 until July 2019, we performed MH decompression surgeries in 
over 269 patients with either frontal, occipital, or temporal migraine trigger sites 
[2, 13–17, 26–28].
As concern the frontal migraine we performed 72 decompression surger-
ies (65 bilateral and 7 unilateral). After a mean follow-up of 24 months (range: 
12–97 months), patients with frontal trigger site migraine reported a 94% positive 
response to surgery (32% complete relief and 62% significant improvement), 
while 6% had no change in their symptoms. Among total patients underwent MH 
frontal decompression surgeries, 24 patients (34.2%) experienced secondary trigger 
point emergence following primary occipital and/or temporal migraine surgery. 
Figure 3. 
Cauterization of ectasic occipital artery (OA) with decompression of greater occipital nerve (GON).
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Among these, 20 patients had two trigger points (18 frontal and occipital, 2 frontal 
and temporal) while 4 patients had all three trigger points. All patients continue 
to experience a quality of life better than before surgery, and all would have the 
surgery again. The learning curve and the experience of the operator play also an 
important role when evaluating clinical outcomes (Figure 4).
Decompression surgeries to treat temporal trigger point were 56. Among these, 
53 had monolateral localization, while 3 had bilateral one. Because the ATN-STA 
close relationship was observed intraoperatively in 47 surgeries the only ATN 
decompressions were performed. Whereas ZTN deactivation procedures were per-
formed during the same operative session 6 times, since no ATN-STA close relation-
ship was encountered. Therefore, we observed ATN-STA close relationship in 85.3% 
of patients; single STA-ATN intersection accounted for 83.7% of the cases, while 
helical intertwining accounted for 16.3%. After a mean follow-up of 24 months 
(range, 3–67 months), patients complaining for temporal MH had 83% positive 
surgical outcome (50% complete MH elimination, 33% significant improvement). 
Among total MH temporal decompression surgeries, 29 patients (49%) experienced 
secondary or tertiary trigger point emergence following primary migraine surgery. 
Among these 22 had two trigger points (20 temporal and occipital, 2 frontal and 
occipital) while 4 patients had all three trigger points (Figure 5).
As concern occipital migraine we performed 141 decompression surgeries (94 
bilateral and 47 unilateral). In 119 patients with occipital migraine, we found a 
dilated occipital artery in close connection with the GON and we ligated the vessel 
without any other surgical maneuvers. In 22 patients with occipital migraine, 
vascular compression was not found and we adopted a conventional approach based 
on neurolysis of the GON and LON from muscles. We gathered data from question-
naires completed before and after surgery. After a mean follow up of 24 months 
(range: 3–67 months), patients with occipital migraine had positive response in 
94.9% (86.8% complete relief and 8.1% significant improvement), and 5.1% did not 
get any better. As for the 119 patients who underwent dilated occipital artery liga-
tion, positive response 95.5% (90% complete relief and 5.5% significant improve-
ment) and 4.5% did not get any better. As for the 22 patients who did not undergo 
occipital artery ligation, we observed positive response in 91% (76% complete 
relief and 15% significant improvement) of the subjects while 9% did not get any 
better. All the patients without improvement of the symptoms after occipital artery 
ligation (3.5%) suffered of unilateral occipital migraine and referred complete relief 
after contralateral secondary surgery. Total patients underwent MH decompression 
Figure 4. 
Results of fontal migraine decompression surgeries from June 2011 until July 2019.
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surgeries, 42 patients (29.7%) experienced secondary or tertiary trigger point 
emergence following primary migraine surgery. Among these, 38 patients had two 
trigger points (18 occipital and frontal, 20 occipital and temporal) while 4 patients 
had all three trigger points (Figure 6).
4. Complications
Migraine surgery is regarded as a minimally invasive procedure; thus, no 
concerning side effects are usually reported. Temporary anesthesia occurred in all 
patients, which lasted 163 days on average [2, 13–17, 26–29]. Minor and transient 
complications reported in literature are lasting occipital numbness, intense itch-
ing after surgery, hypertrophic scar, incisional cellulitis, transient mild incisional 
alopecia or hair thinning, lasting neck stiffness that have an incidence ranging from 
1 to 5% [2, 13–17, 26–29]. As regard our experience, intense itching after surgery 
was present in 30% of patients, temporary anesthesia in all patients while postop-
erative infections, seromas, or hematomas were not observed. All patients that were 
refractory to surgery did not report worsening in their MH at any follow-up. As 
concern frontal migraine decompression surgeries all patients experienced frontal 
and/or upper eyelid edema of various degrees. Usually the edema resolves by the 
Figure 5. 
Results of temporal migraine decompression surgeries from June 2011 until July 2019.
Figure 6. 
Results of occipital migraine decompression surgeries from June 2011 until July 2019.
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fifth postoperative day. Ecchymosis of both upper and lower eyelids follows surgery. 
No treatment needed to be given as these collateral events resolve by themselves; 
boric water applications three times a day helped the process of reabsorption of the 
edema. As previously stated, the only hypothetical serious complication that might 
occur within the 12 h following the surgery is the compression of the optical nerve 
due to the descent of the edema into the posterior orbicular space. In these cases, 
prompt recognition of patient’s sight modification is mandatory in order to urgently 
decompress the optic nerve. Patients with particularly thin skin of the frontal region 
may develop postoperative burn-like scar because of the endoscopic electrocautery. 
The most common complication after site temporal migraine surgeries is slight 
hollowing of the temple (54% incidence rate). Nerve avulsion might be associated 
with neuroma formation, although it is not reported in literature of any neuroma 
following avulsion of ATN and/or ZTN [2, 13–17, 26–28].
Based on our data collected, secondary trigger point emergence following 
primary occipital migraine surgery occurred in 35% of patients. However, we 
routinely deactivate the main trigger site first, and then a second or third surgery 
is performed at the remaining sites 3 months after each surgery. MH recurrence 
may occur from 1 up to 3 months after surgery; thus the result may be regarded as 
permanent only after the third postoperative month [2, 13–17, 26–28].
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